| 1 |
Zanatta A, Carturan E, Rizzo S, et al. Story telling of myocarditis[J]. Int J Cardiol, 2019, 294: 61-64.
|
| 2 |
Grist NR, Bell EJ. A six-year study of coxsackievirus B infections in heart disease[J]. J Hyg (Lond), 1974, 73 (2): 165-172.
|
| 3 |
Breinholt JP, Moulik M, Dreyer WJ, et al. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients[J]. J Heart Lung Transplant, 2010, 29 (7): 739-746.
|
| 4 |
Fairweather D, Cooper LT Jr, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy[J]. Curr Probl Cardiol, 2013, 38 (1): 7-46.
|
| 5 |
Ozieranski K, Tyminska A, Chabior A, et al. Sex differences in incidence, management, and outcomes in adult patients aged over 20 years with clinically diagnosed myocarditis in the last 10 years: data from the MYO-PL nationwide database[J]. Pol Arch Intern Med, 2022, 132 (4): 16199.
|
| 6 |
Kragholm KH, Lindgren FL, Zaremba T, et al. Mortality and ventricular arrhythmia after acute myocarditis: a nationwide registry-based follow-up study[J]. Open Heart, 2021, 8 (2): e001806.
|
| 7 |
Ruiz-Ortiz M, Anguita-Sánchez M, Bonilla-Palomas JL, et al. Incidence and outcomes of hospital treated acute myocarditis from 2003 to 2015 in Spain[J]. Eur J Clin Invest, 2021, 51 (4): e13444.
|
| 8 |
Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children[J]. JAMA, 2006, 296 (15): 1867-1876.
|
| 9 |
Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians[J]. Med J Aust, 2004, 180 (3): 110-112.
|
| 10 |
Maron BJ, Levine BD, Washington RL, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: preparticipation screening for cardiovascular disease in competitive athletes: a scientific statement from the American Heart Association and American College of Cardiology[J]. Circulation, 2015, 132 (22): e267-e272.
|
| 11 |
Richardson P, Mckenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies[J]. Circulation, 1996, 93 (5): 841-842.
|
| 12 |
Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification[J]. Am J Cardiovasc Pathol, 1987, 1 (1): 3-14.
|
| 13 |
Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J, 2013, 34 (33): 2636-2648, 2648a-2648d.
|
| 14 |
Maisch B, Ruppert V, Pankuweit S. Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options[J]. Curr Heart Fail Rep, 2014, 11 (2): 166-177.
|
| 15 |
Hang W, Chen C, Seubert JM, et al. Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes[J]. Signal Transduct Target Ther, 2020, 5 (1): 287.
|
| 16 |
Wang D, Li S, Jiang J, et al. Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis[J]. Sci China Life Sci, 2019, 62 (2): 187-202.
|
| 17 |
Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis[J]. J Am Coll Cardiol, 2012, 59 (9): 779-792.
|
| 18 |
Klingel K, Sauter M, Bock CT, et al. Molecular pathology of inflammatory cardiomyopathy[J]. Med Microbiol Immunol, 2004, 193 (2-3): 101-107.
|
| 19 |
Fairley CK, Ryan M, Wall PG, et al. The organisms reported to cause infective myocarditis and pericarditis in England and Wales[J]. J Infect, 1996, 32 (3): 223-225.
|
| 20 |
Pollack A, Kontorovich AR, Fuster V, et al. Viral myocarditis—diagnosis, treatment options, and current controversies[J]. Nat Rev Cardiol, 2015, 12 (11): 670-680.
|
| 21 |
Tschope C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions[J]. Nat Rev Cardiol, 2021, 18 (3): 169-193.
|
| 22 |
Kühl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction[J]. Circulation, 2005, 111 (7): 887-893.
|
| 23 |
Ukimura A, Satomi H, Ooi Y, et al. Myocarditis associated with influenza A H1N1pdm2009[J]. Influenza Res Treat, 2012, 2012: 351979.
|
| 24 |
Van Linthout S, Klingel K, Tschope C. SARS-CoV-2-related myocarditis-like syndromes Shakespeare's question: what's in a name?[J]. Eur J Heart Fail, 2020, 22 (6): 922-925.
|
| 25 |
Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction[J]. Circulation, 1999, 99 (10): 1348-1354.
|
| 26 |
Woodruff JF. Viral myocarditis. A review[J]. Am J Pathol, 1980, 101 (2): 425-484.
|
| 27 |
Sagar S, Liu PP, Cooper LT Jr. Myocarditis[J]. Lancet, 2012, 379 (9817): 738-747.
|
| 28 |
Puleo PR, Guadagno PA, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB[J]. Circulation, 1990, 82 (3): 759-764.
|
| 29 |
Puleo PR, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction[J]. N Engl J Med, 1994, 331 (9): 561-566.
|
| 30 |
Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates[J]. Circulation, 1997, 95 (1): 163-168.
|
| 31 |
Mahfoud F, Gartner B, Kindermann M, et al. Virus serology in patients with suspected myocarditis: utility or futility?[J]. Eur Heart J, 2011, 32 (7): 897-903.
|
| 32 |
Dec GW Jr, Waldman H, Southern J, et al. Viral myocarditis mimicking acute myocardial infarction[J]. J Am Coll Cardiol, 1992, 20 (1): 85-89.
|
| 33 |
Kühl U, Pauschinger M, Bock T, et al. Parvovirus B19 infection mimicking acute myocardial infarction[J]. Circulation, 2003, 108 (8): 945-950.
|
| 34 |
Morgera T, Di Lenarda A, Dreas L, et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes[J]. Am Heart J, 1992, 124 (2): 455-467.
|
| 35 |
Felker GM, Boehmer JP, Hruban RH, et al. Echocardiographic findings in fulminant and acute myocarditis[J]. J Am Coll Cardiol, 2000, 36 (1): 227-232.
|
| 36 |
Yilmaz A, Ferreira V, Klingel K, et al. Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis[J]. Heart Fail Rev, 2013, 18 (6): 747-760.
|
| 37 |
McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2012, 33 (14): 1787-1847.
|
| 38 |
Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches[J]. J Am Coll Cardiol, 2005, 45 (11): 1815-1822.
|
| 39 |
Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper[J]. J Am Coll Cardiol, 2009, 53 (17): 1475-1487.
|
| 40 |
Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence[J]. Radiology, 2008, 246 (2): 401-409.
|
| 41 |
Francone M, Chimenti C, Galea N, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis[J]. JACC Cardiovasc Imaging, 2014, 7 (3): 254-263.
|
| 42 |
Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations[J]. J Am Coll Cardiol, 2018, 72 (24): 3158-3176.
|
| 43 |
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42 (36): 3599-3726.
|
| 44 |
Blanco-Dominguez R, Sánchez-Díaz R, de la Fuente H, et al. A novel circulating microRNA for the detection of acute myocarditis[J]. N Engl J Med, 2021, 384 (21): 2014-2027.
|
| 45 |
Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development[J]. Nat Rev Drug Discov, 2013, 12 (11): 847-865.
|
| 46 |
Kuehl U, Lassner D, Gast M, et al. Differential cardiac microRNA expression predicts the clinical course in human enterovirus cardiomyopathy[J]. Circ Heart Fail, 2015, 8 (3): 605-618.
|
| 47 |
Li Y, Kowdley KV. MicroRNAs in common human diseases[J]. Genomics Proteomics Bioinformatics, 2012, 10 (5): 246-253.
|
| 48 |
Corsten MF, Dennert R, Jochems S, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease[J]. Circ Cardiovasc Genet, 2010, 3 (6): 499-506.
|
| 49 |
Krueger GR, Ablashi DV. Human herpesvirus-6: a short review of its biological behavior[J]. Intervirology, 2003, 46 (5): 257-269.
|
| 50 |
Ntusi N, O'Dwyer E, Dorrell L, et al. HIV-1-related cardiovascular disease is associated with chronic inflammation, frequent pericardial effusions, and probable myocardial edema[J]. Circ Cardiovasc Imaging, 2016, 9 (3): e004430.
|
| 51 |
Remick J, Georgiopoulou V, Marti C, et al. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research[J]. Circulation, 2014, 129 (17): 1781-1789.
|
| 52 |
Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology[J]. J Allergy Clin Immunol, 2006, 117 (4 Suppl): S525-S553.
|
| 53 |
Menghini VV, Savcenko V, Olson LJ, et al. Combined immunosuppression for the treatment of idiopathic giant cell myocarditis[J]. Mayo Clin Proc, 1999, 74 (12): 1221-1226.
|
| 54 |
徐斯驰，闫杰，卞洲艳，等. 丙种球蛋白对成人心肌炎患者影响的Meta分析[J/OL]. 中华危重症医学杂志（电子版），2019，12（6）：393-401.
|
| 55 |
Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association[J]. Circulation, 2016, 134 (23): e579-e646.
|
| 56 |
Boehmer JP, Starling RC, Cooper LT, et al. Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy[J]. J Card Fail, 2012, 18 (10): 755-761.
|
| 57 |
Atluri P, Ullery BW, MacArthur JW, et al. Rapid onset of fulminant myocarditis portends a favourable prognosis and the ability to bridge mechanical circulatory support to recovery[J]. Eur J Cardiothorac Surg, 2013, 43 (2): 379-382.
|
| 58 |
Chen JM, Spanier TB, Gonzalez JJ, et al. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance[J]. J Heart Lung Transplant, 1999, 18 (4): 351-357.
|
| 59 |
Cooper LT Jr. Myocarditis[J]. N Engl J Med, 2009, 360 (15): 1526-1538.
|
| 60 |
Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology[J]. Circulation, 2015, 132 (22): e273-e280.
|
| 61 |
Eichhorn C, Bière L, Schnell F, et al. Myocarditis in athletes is a challenge: diagnosis, risk stratification, and uncertainties[J]. JACC Cardiovasc Imaging, 2020, 13 (2 Pt 1): 494-507.
|